Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rebound in prevalence and intensity of Onchocerca volvulus infection five years after cessation of alternative treatment strategies in the Massangam Health District, West Region, Cameroon: need for coordinated and sustained efforts.

PLoS neglected tropical diseases·2025
Same author

Genetic structuring and estimation of reproductive adults in Onchocerca volvulus: A genome-wide analysis across hosts and regions.

PLoS neglected tropical diseases·2025
Same author

Levels of Amyloid Beta (<i>Aβ</i>) Expression in the <i>Caenorhabditis elegans</i> Neurons Influence the Onset and Severity of Neuronally Mediated Phenotypes.

Cells·2024
Same author

Synthesizing environmental, epidemiological and vector and parasite genetic data to assist decision making for disease elimination.

Molecular ecology·2024
Same author

Cytotaxonomic characterization and estimation of migration patterns of onchocerciasis vectors (Simulium damnosum sensu lato) in northwestern Ethiopia based on RADSeq data.

PLoS neglected tropical diseases·2024
Same author

Genome-based tools for onchocerciasis elimination: utility of the mitochondrial genome for delineating Onchocerca volvulus transmission zones.

International journal for parasitology·2023
Same journal

Why Next-generation mechanistic models Will transform drug discovery: integrating efficacy and safety.

Expert opinion on drug discovery·2026
Same journal

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.

Expert opinion on drug discovery·2026
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays
05:19

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Published on: August 1, 2025

Target identification and validation for anthelmintic discovery.

Warwick N Grant1, Carolyn A Behm

  • 1La Trobe University, Genetics Department, Bundoora, Vic 3085, Australia +61 3 9479 5067 ; +61 3 9479 5067 ; w.grant@latrobe.edu.au.

Expert Opinion on Drug Discovery
|March 16, 2013
PubMed
Summary
This summary is machine-generated.

New anthelmintic drug discovery requires novel molecular targets. RNA interference in nematodes offers a powerful tool for identifying and validating these targets, advancing drug development pipelines.

More Related Videos

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Assessment of The Effect of Antidiarrheal Drugs and Plant Extracts on Drosophila melanogaster
07:38

Assessment of The Effect of Antidiarrheal Drugs and Plant Extracts on Drosophila melanogaster

Published on: November 17, 2023

Related Experiment Videos

Last Updated: May 13, 2026

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays
05:19

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Published on: August 1, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Assessment of The Effect of Antidiarrheal Drugs and Plant Extracts on Drosophila melanogaster
07:38

Assessment of The Effect of Antidiarrheal Drugs and Plant Extracts on Drosophila melanogaster

Published on: November 17, 2023

Area of Science:

  • Parasitology
  • Drug Discovery
  • Genomics

Background:

  • Current anthelmintics were discovered via empirical screening.
  • Modern drug discovery relies on genetic and genomic target identification.
  • Existing anthelmintics target only three molecular pathways, necessitating new targets.

Purpose of the Study:

  • To outline an idealized drug discovery pipeline for nematode anthelmintics.
  • To critically discuss methods for identifying and validating new drug targets.

Main Methods:

  • Review of current anthelmintic discovery approaches.
  • Discussion of genetic, bioinformatic, and genomic target identification.
  • Emphasis on RNA interference for target validation in nematodes and Caenorhabditis elegans.

Main Results:

  • Existing anthelmintic targets are limited.
  • Functional genomics in helminths is underdeveloped.
  • RNA interference is the most viable technology for target discovery and validation.

Conclusions:

  • Novel molecular targets are urgently needed for anthelmintic development.
  • RNA interference technology is crucial for advancing anthelmintic drug discovery pipelines.
  • A structured approach is required to identify and validate new targets.